219 related articles for article (PubMed ID: 33627786)
1. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
Morgan EL; Patterson MR; Barba-Moreno D; Scarth JA; Wilson A; Macdonald A
Oncogene; 2021 Mar; 40(11):2112-2129. PubMed ID: 33627786
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.
Zhang S; Zhang M; Jing Y; Yin X; Ma P; Zhang Z; Wang X; Di W; Zhuang G
Nat Commun; 2018 Jan; 9(1):215. PubMed ID: 29335437
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based classification of deubiquitinase USP26 and its cell proliferation inhibition through stabilizing KLF6 in cervical cancer.
Ye Y; Li M; Pan Q; Fang X; Yang H; Dong B; Yang J; Zheng Y; Zhang R; Liao Z
Comput Biol Med; 2024 Jan; 168():107745. PubMed ID: 38064851
[TBL] [Abstract][Full Text] [Related]
4. USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation.
Ma C; Wang D; Tian Z; Gao W; Zang Y; Qian L; Xu X; Jia J; Liu Z
Oncogene; 2023 Jul; 42(29):2249-2262. PubMed ID: 37311811
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase USP13 promotes the epithelial-mesenchymal transition and metastasis in gastric cancer by maintaining Snail protein.
Zhang T; Zheng J; Qiao L; Zhao W
Pathol Res Pract; 2022 Jan; 229():153705. PubMed ID: 34872023
[TBL] [Abstract][Full Text] [Related]
6. The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.
Wang B; Ni Z; Dai X; Qin L; Li X; Xu L; Lian J; He F
Mol Cancer; 2014 Apr; 13():98. PubMed ID: 24779770
[TBL] [Abstract][Full Text] [Related]
7. Amplification of USP13 drives ovarian cancer metabolism.
Han C; Yang L; Choi HH; Baddour J; Achreja A; Liu Y; Li Y; Li J; Wan G; Huang C; Ji G; Zhang X; Nagrath D; Lu X
Nat Commun; 2016 Nov; 7():13525. PubMed ID: 27892457
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation.
Li L; Wei J; Li S; Jacko AM; Weathington NM; Mallampalli RK; Zhao J; Zhao Y
EBioMedicine; 2019 Jul; 45():553-562. PubMed ID: 31204278
[TBL] [Abstract][Full Text] [Related]
9. USP13 regulates the replication stress response by deubiquitinating TopBP1.
Kim W; Zhao F; Gao H; Qin S; Hou J; Deng M; Kloeber JA; Huang J; Zhou Q; Guo G; Gao M; Zeng X; Zhu S; Tu X; Wu Z; Zhang Y; Yin P; Kaufmann SH; Luo K; Lou Z
DNA Repair (Amst); 2021 Apr; 100():103063. PubMed ID: 33592542
[TBL] [Abstract][Full Text] [Related]
10. Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development.
He J; Wu S; Li X; Tang L; Chen H; Qin L; Xie J; Lu T; Xu W
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1600-1610. PubMed ID: 32378766
[TBL] [Abstract][Full Text] [Related]
11. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer.
Nakajima W; Hicks MA; Tanaka N; Krystal GW; Harada H
Cell Death Dis; 2014 Feb; 5(2):e1052. PubMed ID: 24525728
[TBL] [Abstract][Full Text] [Related]
12. ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.
Cui X; Yu H; Yao J; Li J; Li Z; Jiang Z
BMC Cancer; 2022 Dec; 22(1):1350. PubMed ID: 36564767
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide reduces USP13 stability through c-Jun N-terminal kinase activation in Kupffer cells.
Yu F; Li Y; Ye Q; Miao J; Taleb SJ; Zhao Y; Zhao J
J Cell Physiol; 2021 Jun; 236(6):4360-4368. PubMed ID: 33169399
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m
Wang C; Meng Y; Zhao J; Ma J; Zhao Y; Gao R; Liu W; Zhou X
Int J Biol Sci; 2023; 19(7):2289-2303. PubMed ID: 37151889
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
[TBL] [Abstract][Full Text] [Related]
16. MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.
Hiraki M; Suzuki Y; Alam M; Hinohara K; Hasegawa M; Jin C; Kharbanda S; Kufe D
Sci Rep; 2016 May; 6():26643. PubMed ID: 27217294
[TBL] [Abstract][Full Text] [Related]
17. USP13 genetics and expression in a family with thyroid cancer.
Maria AG; Azevedo B; Settas N; Hannah-Shmouni F; Stratakis CA; Faucz FR
Endocrine; 2022 Aug; 77(2):281-290. PubMed ID: 35583846
[TBL] [Abstract][Full Text] [Related]
18. USP13 interacts with cohesin and regulates its ubiquitination in human cells.
He X; Kim JS; Diaz-Martinez LA; Han C; Lane WS; Budnik B; Waldman T
J Biol Chem; 2021; 296():100194. PubMed ID: 33334891
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
[TBL] [Abstract][Full Text] [Related]
20. USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity.
Shin J; Kim YH; Lee B; Chang JH; Choi HY; Lee H; Song KC; Kwak MS; Choi JE; Shin JS
Mol Med; 2022 Dec; 28(1):164. PubMed ID: 36585612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
